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ABSTRACT
The proportion of infective endocarditis (IE) caused by group D streptococci (GDS; formerly
Streptococcus bovis) increased markedly in France, to account for 25% of all cases of IE by 1999. In an
attempt to explain this phenomenon, a comparative analysis of GDS and oral streptococci (OS) causing
IE was performed. This study was based on data collected from a large cross-sectional population-based
survey that was conducted in 1999. In total, 559 cases of definite IE were recorded, of which 142 involved
GDS and 79 involved OS. Patients with GDS IE were older (62.7 vs. 56.6 years, p 0.01) and had a history
of valve disease less frequently than did patients with OS IE (33.8% vs. 67.1%, p <0.0001). At-risk
procedures for IE were performed less frequently in patients with GDS than in patients with OS (14.8%
vs. 24.1%, p 0.08), but co-morbidities were more frequent in the GDS group (59.9% vs. 32.9%, p 0.0001).
Diabetes, colon diseases and cirrhosis were also more frequent in the GDS group (p 0.006, p <0.0001 and
p 0.08, respectively). Rural residents accounted for 31.0% of the GDS group, but for only 15.2% of the
OS group (p 0.001). Likewise, the proportion of GDS IE was higher in regions with mixed (urban and
rural) populations (Franche-Comte´ 81.8%, Marne 68.7%, Lorraine 70.3% and Rhoˆne-Alpes 65.3%) than
in exclusively urban regions (Paris and Ile de France 58.0%). Further investigations are required to
elucidate the link in France between the incidence of GDS IE, rural residency and nutritional factors.
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INTRODUCTION
As shown by numerous epidemiological surveys,
the profile of infective endocarditis (IE) has
changed dramatically in recent decades [1–5].
The proportion of IE caused by Staphylococcus
aureus and other nosocomial pathogens is increas-
ing, while the frequency of IE caused by oral
streptococci (OS) is decreasing, particularly in
northern Europe and the USA [6–8]. OS remain
the primary cause of IE in southern Europe and
South America [9]. Analysis of regional variations
as part of the International Collaboration on
Endocarditis study [10] revealed that group D
streptococci (GDS) are an emerging cause of IE,
especially in European countries, and particularly
in France, Spain and Italy [9].
GDS formerly included two species named
Streptococcus bovis and Streptococcus equinus,
which were distinct from enterococci [11]. New
species have now been described within the
Strep. bovis–Strep. equinus complex [12–17], and
the taxonomy of the related species has been
clarified [17,18]. The term GDS is used in the
present study to designate the different species
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belonging to the Strep. bovis–Strep. equinus
complex.
Clinical and epidemiological features of GDS
IE reported in the literature include a higher age
at onset, an increased frequency of co-morbid
conditions, the development of IE despite the
absence of a history of valve disease, and multi-
valvular involvement [9,19]. In addition to an
association of GDS IE with colonic tumours
[20,21], evidence of a correlation with chronic
liver disease has been presented [22]. However,
risk-factors for acquisition of GDS IE have not
yet been clearly identified. The high frequency of
GDS IE in France [2] might be attributed, in part,
to nutritional or other environmental factors.
Nutritional habits in France, such as frequent
consumption of uncooked meat and fresh milk
products, might have an impact on GDS intes-
tinal colonisation and subsequent GDS bacterae-
mia and IE. In order to examine this hypothesis,
a comparative analysis of cases of OS IE and
GDS IE was performed.
PATIENTS AND METHODS
Cases of IE analysed in this study were collected during a
cross-sectional prospective multi-regional population-based
survey that was conducted in France during 1999. This survey
included seven geographical areas: Lorraine, Ile-de France,
Franche-Comte´, Marne, Rhoˆne-Alpes, Nouvelle–Cale´donie
and Gironde. The methods and main results of this survey
have been published previously [2]. In brief, the survey was
conducted between 1 December 1998 and 31 March 2000.
During this period, 653 cases of IE were entered into the
database. All case report forms were checked and validated by
two expert investigators who had not been involved in the care
of the corresponding patients. These investigators were
responsible for validating the diagnosis of IE according to
the Duke criteria [23]. This process excluded 94 cases; the
remaining 559 cases of definite IE were included in the study
[2]. Standard variables, e.g., demographical and predisposing
factors, clinical picture and outcome, were investigated, as
well as variables such as residence (rural or urban residency at
the time of IE diagnosis), nutritional habits (consumption of
milk, unprotected water, meat, fish and shellfish) and animal
contacts (cattle, rodents and pets). Predisposing factors for IE
included pre-existing valvulopathy (i.e., valve prolapse, regur-
gitation, stenosis, bicuspid aortic valve), injecting drug use and
the presence of a prosthetic valve. At-risk medical or surgical
procedures for IE were also recorded. Co-morbidities recorded
included diabetes mellitus, cardiovascular disease (i.e., arterial
hypertension, coronary heart disease, stroke, dyslipidaemia),
respiratory disorders, renal failure, immunodeficiency (i.e.,
treatment with corticosteroids or other immunosuppressive
agents, human immunodeficiency virus infection, splenecto-
my), malignancies, cirrhosis and colon diseases (i.e., diverti-
culosis, adenoma, adenocarcinoma, ischaemic or inflammatory
lesions). Clinical characteristics of IE included fever, cardiac
murmurs, vascular manifestations (i.e., Janeway lesions, cer-
ebral and ⁄ or conjunctival haemorrhage), purpura, immunolo-
gical manifestations (i.e., Roth spots, Osler nodes, rheumatoid
factor), embolic events and metastatic infectious foci resulting
from bacteraemia (i.e., vertebral osteomyelitis and septic
arthritis). Multi-valvular involvement was defined as echocar-
diography findings consistent with IE in more than one valve.
Severe cardiac failure was defined as grades III–IV of the New
York Heart Association definitions [24].
Microbiologists were asked to complete a form that request-
ed information concerning the identification and antibiotic
susceptibilities of the causative microorganism (total number
and number of positive blood cultures, results of valve
cultures and serological tests). Almost half (46.6%) of the
streptococcal isolates were submitted to the Centre National de
Re´fe´rence des Streptocoques (Paris, France) and were identi-
fied to the species and subspecies levels according to the
current classification of GDS and OS. All isolates were Gram-
positive catalase-negative cocci arranged in pairs or chains,
and were identified as streptococci according to their pheno-
typic characteristics. a-Haemolysis, or the absence of haemo-
lysis, was observed around colonies grown on Columbia sheep
blood agar. Gas was not produced in de Man, Rogosa and
Sharpe broth, the pyrrolidonyl-arylamidase rapid test was
negative, and the isolates were susceptible to vancomycin. The
isolates were also tested for growth on bile-aesculin agar and
in Todd–Hewitt broth containing NaCl 6.5% w ⁄v. Biochemical
traits were determined using the Rapid ID32 STREP identifi-
cation system (bioMe´rieux, Marcy l’Etoile, France). When the
isolate could not be assigned to an individual species because
of atypical results, a 1500-bp fragment of the 16S rRNA gene
was amplified with primers 27f and 1525r, according to the
method of Tee et al. [25], and 16S rRNA gene sequence analysis
was performed [26].
According to the current taxonomy [18], isolates identified
as Streptococcus mitis, Streptococcus oralis, Streptococcus sangui-
nis, Streptococcus gordonii, Streptococcus parasanguinis, Strepto-
coccus mutans or Streptococcus salivarius were included in the
OS group, and those identified as Streptococcus gallolyticus,
Streptococcus pasteurianus, Streptococcus infantarius or Strep.
bovis were included in the GDS group. Streptococci belonging
to the Streptococcus anginosus group (formerly the milleri
group), which includes Strep. anginosus, Streptococcus con-
stellatus and Streptococcus intermedius, were not included in
the present study.
Continuous variables were calculated as means ± SD, while
categorical variables were calculated as percentages. Mann–
Whitney rank sum and chi-square tests were used to evaluate
quantitative and qualitative variables, respectively, with
p <0.05 considered to be statistically significant. All statistical
analyses were performed using BMDP software (BMDP
Statistical Software, Los Angeles, CA, USA).
RESULTS
Of the 559 cases of IE, there were 142 and 79 cases
of GDS and OS IE, respectively (Table 1). Most
GDS isolates were identified as Strep. gallolyticus,
or had been identified as Strep. bovis if they had
not been sent for further identification at the
Centre National de Re´fe´rence des Streptocoques.
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Strep. mitis and Strep. oralis were the OS isolated
most frequently.
Demographics and risk-factors for GDS IE and
OS IE are summarised in Table 2. GDS IE pre-
dominated among the elderly, and both GDS IE
and OS IE affected males more frequently than
females. There was a significant difference
between the GDS and OS groups in the mean
weight of patients, but not in body mass index
values (Table 2). Residency in a rural area was
significantly more frequent for patients with GDS
IE (31.0 vs. 15.2%, p 0.001). Unfortunately, the
role of nutritional habits could not be assessed
because of numerous missing data. Animal con-
tacts were as frequent in the GDS as in the OS
group (23.9% vs. 25.3%, p 0.6). The proportion of
cases of GDS IE was higher in Franche-Comte´
(81.8%), Marne (68.7%), Rhoˆne-Alpes (65.3%)
and Lorraine (70.3%) than in Ile de France
(58.3%), an exclusively urban area (Fig. 1). How-
ever, comparison of the standardised incidences
of GDS IE was not as demonstrative. Thus,
although the highest incidence was observed in
a rural region (Marne, 23.9 cases ⁄million), the
incidence observed in Ile de France
(11.4 cases ⁄million), which is an industrialised
and urban region, was intermediate compared
Table 1. Identification of group D streptococci (GDS) and
oral streptococci (OS) isolates responsible for cases of
infective endocarditis
Isolates n %
Total GDS 142 64
Identified GDSa 79 56
Streptococcus gallolyticus 71 50
Streptococcus infantarius 5 4
Streptococcus pasteurianus 3 2
Unspeciated GDSb 63 44
Total OS 79 36
Streptococcus sanguinis 14 18
Streptococcus mitis 27 34
Streptococcus salivarius 2 3
Streptococcus mutans 7 9
Streptococcus oralis 23 29
Streptococcus parasanguinis 2 3
Streptococcus gordonii 4 5
aIsolates of GDS were identified according to the current taxonomy.
bIsolates identified as Streptococcus bovis, but not further identified according to the
current taxonomy.
Table 2. Demographics, risk-factors
and clinical ⁄ echocardiographical data
for cases of infective endocarditis (IE)
caused by group D streptococci





(n = 79) p
Demographics ⁄ risk-factors
Age, mean ± SD 62.7 ± 13.3 56.6 ± 16.1 0.01
Male, n (%) 116 (81.7) 60 (75.9) 0.3
Body mass index, mean ± SD 24.2 ± 4.8 24.2 ± 3.9 0.8
Cigarette smoker, n (%) 32 (22.5) 23 (29.1) 0.2
Rural residency, n (%) 44 (31.0) 2 (15.2) 0.001
Pre-existing valvulopathya, n (%) 48 (33.8) 53 (67.1) <0.0001
Co-morbiditiesb, n (%) 85 (59.9) 26 (32.9) 0.0001
Diabetes mellitus 23 (16.2) 1 (1.3) 0.006
Cirrhosis 12 (8.5) 2 (2.5) 0.08
Colon diseasesc 71 (50) 9 (11.4) <0.0001
Clinical and echocardiographical data, n (%)
Murmur 117 (82.4) 73 (92.4) 0.04
Fever 124 (87.3) j 68 (86.1) 0.5
Embolismd 47 (33.1) 25 (31.6) 0.8
Vascular manifestationse 55 (38.7) 28 (35.4) 0.6
Immunological manifestationsf 36 (25.4) 25 (31.6) 0.3
Metastatic infectious focig 10 (7.0) 1 (1.3) 0.1
Congestive heart failureh 41 (19.0) j 16 (15.2)j 0.1
Location of IEi
Mitral valve 54 (38.0) 49 (62.0) 0.0006
Aortic valve 103 (72.5) 36 (45.6) 0.0001
Multi-valvular involvement 36 (27.9) 15 (20.5) 0.2
Intra-cardiac lesions on echocardiography
Vegetations 123 (86.6) 70 (88.6) 0.6
Abscess 22 (15.5) 15 (19) 0.5
Valve regurgitation 133 (93.7) 70 (88.6) 0.1
Outcome
Surgical treatment 73 (51.4) 46 (58.2) 0.6
In-hospital mortality 18 (12.7) 5 (6.3) 0.1
aDefined as valve prolapse, regurgitation, or stenosis and bicuspid aortic valve.
bIncluding cardiovascular disease, diabetes mellitus, malignancy, colon disease, cirrhosis, respiratory disorder,
renal failure and immunodeficiency.
cIncluding diverticulosis, adenoma, adenocarcinoma, and ischaemic or inflammatory lesions of the bowel.
dIncluding stroke, and ocular, hepatic, splenic, coronary, pulmonary, peripheral or renal embolism.
eIncluding Janeway lesions, cerebral haemorrhage and conjunctival haemorrhage.
fIncluding Roth spots, Osler nodes, rheumatoid factor and glomerulonephritis.
gIncluding vertebral osteomyelitis and septic arthritis.
hDefined as New York Heart Association grade ‡III [24].
iValvular location was not confirmed on echocardiography in 13 cases of GDS and six cases of OS.
jData were missing concerning congestive heart failure for 27 cases of GDS and 12 cases of OS, and concerning fever
for two cases of GDS.
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with that observed in Rhoˆne-Alpes, where the
incidence of GDS IE was the lowest
(6.9 cases ⁄million).
Pre-existing valvulopathy was detected more
frequently in the OS than in the GDS group
(Table 2). Several patients with OS and GDS IE
(n = 6 and n = 5, respectively) had a history of IE,
while 11 patients in each group had a prosthetic
valve at the time of onset of IE. Three patients
from the OS group and one from the GDS group
were injecting drug users. Invasive procedures
creating a risk of IE were recorded more often for
the OS than for the GDS group (24.1% vs. 14.8%,
p 0.08), with a trend towards a higher frequency
of dental procedures in the OS group (19% vs.
11.3%, p 0.1).
Co-morbidities, particularly diabetes mellitus,
were detected more frequently in GDS than in OS
patients (Table 2). Cirrhosis was more prevalent
in the GDS group, although the difference was not
statistically significant. Colonic disease was sig-
nificantly more frequent among patients with
GDS IE. However, it should be noted that colon-
oscopy was performed in 64.7% of GDS IE
patients, but in only 20.2% of OS patients. Among
92 of 142 patients with GDS IE who underwent
colonoscopy, colon disease was detected in 71
(77.1%) cases involving adenomas (n = 55,
77.5%), adenocarcinoma (n = 5, 7%) and diverti-
culosis (n = 16, 22.5%), with 30% of adenomas
presenting with a degree of dysplasia. When only
the 46 patients who had Strep. gallolyticus IE and
who underwent colonoscopy were considered,
the distribution of colon abnormalities (n = 32 ⁄ 46,
69.5%) was adenomas n = 24 (75%), adenocarci-
noma n = 3 (9.3%), and diverticulosis n = 10
(31.2%), with 20% of adenomas presenting with
a certain degree of dysplasia.
Clinical and echocardiographical data, as well
as in-hospital outcome, are summarised in
Table 2. Cardiac murmur at the time of diagnosis
was not detected in 17.6% of GDS and 7.6% of OS
IE patients. In addition, a pre-existing murmur
was more prevalent in the OS than in the GDS
group (35.5% vs. 20.6%, p 0.03). Embolic compli-
cations were recorded for one-third of cases in
both groups. However, metastatic foci of the
disease tended to be more frequent in the GDS
group (Table 2). Although vascular manifesta-
tions of IE did not differ significantly, purpura
tended to be more frequent in the GDS than in the
OS group (10.6% vs. 3.8%, respectively, p 0.07).
The rates of congestive heart failure did not differ
statistically between the two groups. Similarly,
laboratory parameters (white blood cell count
>109 ⁄L, serum creatinine >180 lmol ⁄L, and
C-reactive protein >120 mg ⁄L), as well as the
ratio of positive to total blood cultures taken, did
not differ between the two groups.
Vegetations were visualised in >85% and
abscesses in <20% of the cases in both groups.
Valve regurgitation was very common, and was
slightly more frequent in the GDS group. The
aortic valve was involved more frequently in the
GDS group, and the mitral valve in the OS group
(p <0.001); multi-valvular involvement was
detected in <30% of cases in both groups
(Table 2). More than 50% of the patients in both
groups underwent surgical treatment, consisting
mainly of valve replacement. The in-hospital
mortality rate was low in both groups, but there
was a trend towards a higher mortality rate in the
GDS IE group (p 0.1).
DISCUSSION
In France, the proportion of GDS IE increased
during the last 25 years of the 20th century,
reaching 25% in 1999 [2,3,27]. This increase has
not been fully explained to date. To the best of our
knowledge, this is the first investigation of a
possible correlation between rural residency and
a higher proportion of GDS IE. Regional varia-























Fig. 1. Regional variations in the number of cases of
infective endocarditis caused by group D streptococci
(GDS) and oral streptococci (OS) in France.
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lowest proportion of GDS IE being in Ile de
France (Paris and suburbs), which is an almost
exclusively urban area, while the highest propor-
tions of GDS IE were observed in regions charac-
terised by a rural or mixed urban ⁄ rural
population. However, factors that may promote
GDS IE among rural residents require further
elucidation. According to Tripodi et al. [28], the
selection of sporadic, endemic clones of GDS from
the endogenous intestinal flora may play a role in
the incidence of GDS bacteraemia and IE, but the
factors that might influence this phenomenon are
still unknown.
GDS IE affects the elderly more frequently than
does OS IE or staphylococcal IE [29–31]. The
results of the present study are in accordance with
these previous findings, and with recent relevant
observations within the merged International Col-
laboration on Endocarditis database [9]. Increased
age may explain, in part, the increased incidence
of co-morbidities identified in this group of
patients [19,30]. In the present study, diabetes
mellitus was also more frequent in the GDS group,
as reported previously in one study [9].
The clinical characteristics of patients with GDS
IE in the present series were consistent with
previous observations that pre-existing valvulop-
athy was not characteristic of GDS IE [32]. The
results also confirmed the already reported pre-
dilection of GDS IE for the aortic valve [33,34]. It
remains controversial whether multi-valvular
involvement is more frequent in GDS IE, as
reported by Kupferwasser et al. [31] and Hoen
et al. [9], but the present study demonstrated a
lower incidence of multi-valvular GDS IE in
accordance with the findings of Duval et al. [32].
Data concerning embolic manifestations of GDS
IE are also conflicting. Some studies have report-
ed that embolic complications and metastatic foci
are more frequent in GDS IE [22,29,32], and that
both GDS and Staph. aureus IE are associated with
higher rates of embolisation [35]. However, these
findings were discounted by Kupferwasser et al.
[31], and the incidence of embolisation in the
present study did not differ between OS and GDS
IE, in line with other recent data [9]. Cardiac
failure, surgical treatment for IE, and in-hospital
mortality rates were similar for the GDS and OS
groups in the current analysis, as well as in most
previous studies [29]. Taking into account the fact
that GDS IE affects primarily the elderly and
individuals with co-morbidities, in-hospital mor-
tality rates were relatively low (<13%), i.e., far
lower than those for Staph. aureus IE [36],
although higher than those for OS IE.
As established previously, GDS bacteraemia is
more likely to occur in patients with underlying
colon disease, especially adenomas and cancer
[22,32,37]. Tripodi et al. [22] reported a 60% rate
of chronic liver disease in patients with GDS IE,
and a 46.7% rate of colonic adenoma. Colonic
cancer has been clearly associated with GDS IE,
and other colonic lesions, e.g., diverticulosis and
adenomas, which are detected more often in the
elderly, are also associated strongly with GDS IE
[22]. The ability of GDS to bind to epithelial cells
via cell-wall proteins, promoting bacterial coloni-
sation of the intestine and systemic infection of
the host, has been reported [37]. Furthermore,
experimental models have demonstrated a poten-
tial role for GDS in the pathogenesis of colonic
cancer [39,40]. The relatively increased frequency
of adenomas with dysplastic features (>30%) in
patients with GDS IE, as revealed by the present
study, supports this hypothesis. The possible link
between GDS intestinal colonisation and carcino-
genesis requires further investigation. The high
prevalence of colonic disease (69.5%) in the
Strep. gallolyticus subgroup highlights this associ-
ation and the need for further investigation of
potential correlations between some GDS and
colonic disease, including cancer. Unfortunately,
only half of the clinical GDS isolates were fully
speciated in the present analysis.
A major strength of the present study was the
use of a large, prospectively collected group of
well-defined cases of IE from seven regions in
France, together representing >25% of the French
population. Data collection was satisfactory and
there was no evidence of under-reporting by the
participating physicians during the period of the
study. Single-centre studies frequently analyse a
small number of cases [29,32] and are prone to
referral bias. In the present study, the proportion
of GDS IE cases (25%) is one of the highest
described to date [2]. The analysis compared
variables between two streptococcal groups (OS
and GDS) that are similar in terms of virulence
and susceptibility to penicillin [41]. Identification
of the GDS isolates according to the new classifi-
cation criteria revealed Strep. gallolyticus (formerly
Strep. bovis biotype I) to be the most frequent GDS
species involved in IE (Table 1). In a 16-year
prospective study, Strep. bovis type I bacteraemia
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was found previously to be associated more often
with colon tumours and with IE (57% and 74%,
respectively) than was Strep. salivarius and
Strep. bovis type II [42].
To the best of our knowledge, the present study
is the first to investigate the role of environmental
factors in the incidence of GDS IE. However, a
major limitation of the study was the fact that it
was not feasible to investigate the possible associ-
ation between food and alcohol consumption and
the incidence of GDS IE because of important
missing data concerning nutritional habits within
the study population. Further investigations are
required to examine the potential role of nutri-
tional factors and rural residence in GDS intesti-
nal colonisation.
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